26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
18 March 2020
The overall rates of smoking among UK adults and young people have declined in recent decades. Legislation around the consumption, sale and advertisement of cigarettes has become tighter, and wide-reaching public health campaigns have taken effect.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
7 March 2020
A good start in life is critical for health—and this story begins before birth. The WHO states that monitoring maternal and child health during pregnancy is critical, and that smoking is one of the most important modifiable lifestyle choices during this period.
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
3 February 2020
NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.
31 January 2020
The review was commissioned by the Chief Executive of NHS England to assist its Board in the evaluation of responses to a consultation undertaken in summer 2019 relating to a new draft service specification for children’s cancers.
28 January 2020
A joint report by RCPCH and the Royal College of Physicians suggests we need to do more to improve the quality of our indoor air.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.